Rheumatoid Arthritis- Pharmacist


  Credits  1.5

This product is currently out of stock and unavailable.

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease characterized by immune system damage to multiple joints. It results in pain, physical disability, reduced quality of life, increased mortality, and significant socioeconomic costs. The estimated prevalence of RA is 0.5% to 1% of the population worldwide; women are 2 to 3 times more likely to be affected than men. RA can begin at any age; however, the onset is typically during the sixties. Up to 60% to 90% of individuals with RA have progressive destruction of joints, and as many as one-third are work-disabled within 2 years of disease onset. Historically, initial RA treatment focused on corticosteroids and NSAIDs to reduce painful inflammation; eventually, nonresponders were given disease-modifying antirheumatic drugs (DMARDs) such as methotrexate (MTX). Over the last decade, earlier and more aggressive treatment has been recommended to slow disease progression. Newer strategies include combination DMARD regimens and early use of biologic DMARDs that target specific components of the immune system. The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR), have published treatment guidelines for RA that include the use of biologic agents alone or in combination with nonbiologic DMARDs. This issue will briefly review RA in adults, then focus on newer treatments including biologic agents (tumor necrosis factor [TNF] inhibitors and non-TNF inhibitors), delayed-release prednisone (Rayos®), and tofacitinib (Xeljanz®).


Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 0428-0000-13-004-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.